Navigation Links
Patent Issued for Apparel and Textile Fabric with Antimicrobial Properties
Date:5/6/2013

RIDGELAND, Miss. (PRWEB) May 06, 2013

Bert Rubinsky, CEO of Medical Grade Innovations (MGI), is announcing he has been issued a patent by the United States Patent and Trademark Office on fabric with antimicrobial properties. The patent number is 13/207,392.

The fabric, “B++” will first be used to create bactericidal incontinent pads, sheets, pillow cases, patient gowns and operating room apparel and sold to medical institutions and facilities through MGI. Bactericidal is defined as “preventing infection by inhibiting the growth or action of microorganisms.”

“Our goal is to minimize the bacterial pollution in our medical environments. Just because the apparel and textiles within the hospital look clean, doesn’t mean they actually are. Bacterial pathogens on conventional fabrics used in health care settings can grow by 10-fold over a 24-hour period,” said Bert Rubinsky, CEO and founder, Medical Grade Innovations. “There have been many great strides in best practice guidelines and preventative care, but we must also focus on the soft surfaces, such as the patient bed, patient, and health care professional to reduce the incidence of pathogens leading to infections.”

Data from as far back as 1969*, shows that conventional fabric – poly-cotton used by medical institutions and clinics contributes to bacterial pathogen growth. In addition, bacterial pathogens can survive on poly-cotton up to 60 days if unwashed. Independent tests done at Accugen Laboratories showed that B++ fabric was 99.9% effective against inhibiting leading hospital acquired infections including Methicillin-resistant Staphylococcus aureus, E. coli, Klebsiella and Pseudomonas.

“We have our police officers in bullet proof vests and our firefighters in fire retardant clothing. Our chicken farmers even follow strict operational procedures when it comes to apparel,” said Rubinsky. “Our medical professionals and those seeking medical care deserve at least the same protection.”

Medical Grade Innovations also sells a bacteriostatic scrub, doctor coat, and necktie. All Medical Grade Innovations products are made from fabric that has a longer lifecycle and in some cases, lower wash and dry temperatures than what is used in health care today, leading to long-term cost savings.

About Medical Grade Innovations, LLC

Medical Grade Innovations (MGI) aims to reduce opportunities for bacterial pathogen growth, and improve energy efficiency and H2E compliance, by offering better apparel and textile products made from innovative bacteriostatic and bactericidal fabrics. MGI B++ products are 99.9% effective against inhibiting the growth of bacterial pathogens that can lead to hospital acquired infections, such as Methicillin-resistant Staphylococcus aureus, E. coli, Klebsiella and Pseudomonas. MGI’s bacteriostatic scrubs, doctor coats and ties can be washed at home on a cold wash cycle and dried on a low heat setting. The Medical Grade Innovations website is currently under construction.

###

  • R. Speers, et al., “Contamination of Nurses’ Uniforms with Staphylococcus Aureus”, The Lancet; Vol. 294: Issue 7614; pages 233-235; 2, August, 1969.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10701022.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
2. Human Gene Patent Case Goes to Supreme Court
3. A New Alarm Clock App (Patent Pending) Helps to Lose Weight and Fat
4. First of its kind, patented EDC Removing Water Purifier System
5. Diet Pill Prescopodene is First Supplement to Contain Patented Advantra Z Weight Loss Compound
6. Neurological Wellness Center Criticizes the U.S. Patent Office for Issuing a Patent for an Injection Site on the Human Body
7. Method patent issued for investigational new class of pain medication
8. New Patented Technology a Breakthrough for Telehealth Stethoscopes
9. Trustifi Patent 8,341,023 Granted by USPTO and New Patent to be Issued for Postmarked Email
10. Sani-Cast Receives Patent for Under Cast Cleanse System
11. InventHelp Client Patents “LessMess” – Invention Could Reduce Messes and Smells Caused by Splashed Urine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... May 28, 2016 , ... SuperCloset is proud to officially launch our ... to day issues, struggles and obstacles veterans’ need to overcome in order to face ... active or retired military veteran(s) with a donated SuperCloset product based on the needs ...
(Date:5/28/2016)... ... ... After a year and a half of planning the Multiple Pathways of Recovery Conference ... of Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel ... to explore the many pathways individuals use to get into and sustain their recovery. ...
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses and ... to shed lights on the variety of topics detailing why we appreciate nurses in ... why this career has gone from being in a major recession to one of ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... caregivers to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy ... trends and tech within the industry, from leading advocates, associations and industry leaders ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... KONG , May 24, 2016 ... , the world , s first ... AV fistula intervention   OrbusNeich, a global ... has expanded its portfolio to include products to treat ... are the company,s first entry devices for lower limb ...
Breaking Medicine Technology: